Device Trial Radar · NCT04051892
Multicenter Study Evaluating the FixNip™ NRI Safety and Performance
Last checked: Nov 19, 2026Latest source record: Mar 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10
Actual
Start
Oct 6, 2020
Primary completion
Jul 13, 2022
Study completion Dec 22, 2022
Sponsor
- Lead sponsor
- FixNip LtdNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 9, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- Female only, from 22 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A prospective, Open Label, Single arm, Multicenter study Evaluating the FixNip™ NRI Safety and Performance in Female Patients Seeking Reconstructive Surgery of the Nipple.
Conditions
- Reconstruction of the Breast Nipple and Areola Complex
Interventions
FixNip™ NRIDevice
The FixNip™ NRI is an implantable hypodermic, silicone implant specially designed for nipple areola definition
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse eventTime frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Assuta Medical Center
Tel Aviv, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.